1	INTRODUCTION	48
1.1	STUDY OBJECTIVES	48
1.2	MARKET DEFINITION	48
1.2.1	TELEHEALTH	48
1.2.2	TELEMEDICINE	49
1.3	INCLUSIONS & EXCLUSIONS	49
1.4	MARKET SCOPE	50
1.4.1	MARKETS COVERED	50
1.4.2	REGIONS COVERED	51
1.4.3	YEARS CONSIDERED	51
1.4.4	CURRENCY CONSIDERED	52
1.5	RESEARCH LIMITATIONS	52
1.5.1	SCOPE-RELATED LIMITATIONS	52
1.5.2	METHODOLOGY-RELATED LIMITATIONS	52
1.6	STAKEHOLDERS	52
1.7	SUMMARY OF CHANGES	53
1.7.1	RECESSION IMPACT: TELEHEALTH & TELEMEDICINE MARKET	53
2	RESEARCH METHODOLOGY	54
2.1	RESEARCH DATA	54
FIGURE 1	RESEARCH METHODOLOGY: TELEHEALTH & TELEMEDICINE MARKET	54
FIGURE 2	RESEARCH DESIGN	55
2.1.1	SECONDARY DATA	55
2.1.1.1	Secondary sources	56
2.1.2	PRIMARY DATA	57
FIGURE 3	BREAKDOWN OF PRIMARY INTERVIEWS: BY CATEGORY, DESIGNATION, AND REGION	58
2.1.2.1	Primary sources	58
2.1.2.2	Key insights from primary sources	58
2.2	MARKET SIZE ESTIMATION	59
FIGURE 4	RESEARCH METHODOLOGY: HYPOTHESIS BUILDING	59
FIGURE 5	ESTIMATION OF MARKET SIZE FOR REMOTE PATIENT MONITORING SOFTWARE & SERVICES THROUGH ADOPTION-BASED APPROACH	60
FIGURE 6	ESTIMATION OF MARKET SIZE FOR REAL-TIME INTERACTION SOFTWARE & SERVICES THROUGH ADOPTION-BASED APPROACH	60
FIGURE 7	ESTIMATION OF MARKET SIZE FOR STORE-AND-FORWARD SOFTWARE & SERVICES THROUGH ADOPTION-BASED APPROACH	61
FIGURE 8	ESTIMATION OF GLOBAL TELEHEALTH & TELEMEDICINE MARKET SIZE THROUGH ADOPTION-BASED APPROACH	61
2.3	MARKET BREAKDOWN AND DATA TRIANGULATION	63
FIGURE 9	DATA TRIANGULATION METHODOLOGY	63
2.4	STUDY ASSUMPTIONS	64
2.5	RISK ASSESSMENT	64
2.6	IMPACT OF ECONOMIC RECESSION ON TELEHEALTH & TELEMEDICINE MARKET	64
3	EXECUTIVE SUMMARY	66
FIGURE 10	TELEHEALTH & TELEMEDICINE MARKET, BY COMPONENT, 2023 VS. 2028 (USD MILLION)	66
FIGURE 11	TELEHEALTH & TELEMEDICINE MARKET, BY MODE OF DELIVERY, 2023 VS. 2028 (USD MILLION)	67
FIGURE 12	TELEHEALTH & TELEMEDICINE MARKET, BY APPLICATION, 2023 VS. 2028 (USD MILLION)	67
FIGURE 13	TELEHEALTH & TELEMEDICINE MARKET, BY END USER, 2023 VS. 2028 (USD MILLION)	68
FIGURE 14	REGIONAL SNAPSHOT: TELEHEALTH & TELEMEDICINE MARKET	69
4	PREMIUM INSIGHTS	70
4.1	TELEHEALTH & TELEMEDICINE MARKET OVERVIEW	70
FIGURE 15	SHORTAGE OF MEDICAL STAFF, RISE IN CHRONIC DISEASES, AND INCREASED GERIATRIC POPULATION TO DRIVE MARKET	70
4.2	NORTH AMERICA: TELEHEALTH & TELEMEDICINE MARKET, BY COMPONENT AND COUNTRY, 2022	71
FIGURE 16	SOFTWARE & SERVICES SEGMENT AND US DOMINATED NORTH AMERICAN MARKET IN 2022	71
4.3	GEOGRAPHICAL GROWTH OPPORTUNITIES: TELEHEALTH & TELEMEDICINE MARKET	72
FIGURE 17	CHINA TO ACCOUNT FOR HIGHEST CAGR DURING FORECAST PERIOD	72
4.4	TELEHEALTH & TELEMEDICINE MARKET, BY REGION, 2021–2028	73
FIGURE 18	ASIA PACIFIC TO REGISTER HIGHEST GROWTH RATE DURING STUDY PERIOD	73
4.5	DEVELOPED VS. EMERGING ECONOMIES: TELEHEALTH & TELEMEDICINE MARKET	73
FIGURE 19	EMERGING ECONOMIES TO REGISTER HIGHER GROWTH RATE DURING FORECAST PERIOD	73
5	MARKET OVERVIEW	74
5.1	INTRODUCTION	74
5.2	MARKET DYNAMICS	74
FIGURE 20	DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES: TELEHEALTH & TELEMEDICINE MARKET	74
TABLE 1	MARKET DYNAMICS: IMPACT ANALYSIS	75
5.2.1	DRIVERS	76
5.2.1.1	Growing geriatric population and increasing need to expand healthcare access	76
TABLE 2	INCREASE IN POPULATION, 2022, 2030, AND 2050, BY MEDIUM SCENARIO (MILLION)	76
5.2.1.2	Rising prevalence of chronic conditions and cost-benefits of telehealth & telemedicine services	77
TABLE 3	CHRONIC DISEASES AND THEIR COST BURDEN IN US: POTENTIAL FOR SAVINGS	77
5.2.1.3	Shortage of skilled healthcare professionals	78
5.2.1.4	Advancements in telecommunication technologies	78
5.2.1.5	Increased government support and favorable reimbursement policies	78
5.2.2	RESTRAINTS	79
5.2.2.1	Regulatory variations across regions	79
TABLE 4	US: STATE-WISE REGULATORY REQUIREMENTS FOR TELEHEALTH	79
5.2.2.2	Increase in fraud in telehealth practices	80
5.2.2.3	Violation of medical ethics	81
5.2.3	OPPORTUNITIES	81
5.2.3.1	Increased utility of telemedicine against infectious diseases and epidemics	81
5.2.3.2	Use of blockchain technology in healthcare industry	81
5.2.3.3	Increased use of artificial intelligence and big data analytics	82
5.2.3.4	Growing demand for virtual care	83
5.2.4	CHALLENGES	84
5.2.4.1	Inability to maintain hygiene and cleanliness standards	84
5.2.4.2	Behavioral barriers, healthcare affordability, and lack of awareness	84
5.3	INDUSTRY TRENDS	85
TABLE 5	TRENDS IN TELEHEALTH & TELEMEDICINE MARKET	85
5.3.1	OVERVIEW OF USE CASES	86
TABLE 6	OVERVIEW OF TELEHEALTH USE CASES	88
5.4	TECHNOLOGY ANALYSIS	89
5.4.1	MACHINE LEARNING	89
5.4.2	ARTIFICIAL INTELLIGENCE	90
5.4.3	INTERNET OF THINGS	90
5.4.4	BLOCKCHAIN TECHNOLOGY	90
5.4.5	CLOUD COMPUTING	91
5.4.6	DATA ANALYTICS	91
5.4.7	EXTENDED REALITY	91
5.5	CASE STUDY ANALYSIS	92
5.5.1	CASE STUDY 1	92
5.5.2	CASE STUDY 2	93
5.6	ECOSYSTEM MARKET MAP	93
FIGURE 21	ECOSYSTEM MARKET MAP: TELEHEALTH & TELEMEDICINE MARKET	97
5.7	VALUE CHAIN ANALYSIS	98
FIGURE 22	VALUE CHAIN ANALYSIS: TELEHEALTH & TELEMEDICINE MARKET	99
5.8	PORTER’S FIVE FORCES ANALYSIS	99
TABLE 7	PORTER’S FIVE FORCES ANALYSIS: TELEHEALTH & TELEMEDICINE MARKET	99
5.8.1	THREAT OF NEW ENTRANTS	100
5.8.2	THREAT OF SUBSTITUTES	100
5.8.3	BARGAINING POWER OF BUYERS	100
5.8.4	BARGAINING POWER OF SUPPLIERS	100
5.8.5	INTENSITY OF COMPETITIVE RIVALRY	100
5.9	PATENT ANALYSIS	100
5.9.1	PATENT PUBLICATION TRENDS	100
FIGURE 23	PATENT PUBLICATION TRENDS, 2014–2023	101
5.9.2	INSIGHTS: JURISDICTION AND TOP APPLICANT ANALYSIS	101
FIGURE 24	TOP APPLICANTS & OWNERS (COMPANIES/INSTITUTIONS) FOR TELEHEALTH & TELEMEDICINE PATENTS, JANUARY 2013– NOVEMBER 2023	102
FIGURE 25	TOP APPLICANT COUNTRIES/REGIONS FOR TELEHEALTH & TELEMEDICINE PATENTS, JANUARY 2014–OCTOBER 2023	102
5.9.3	LIST OF MAJOR PATENTS	103
TABLE 8	KEY PATENTS IN TELEHEALTH & TELEMEDICINE MARKET	103
5.10	TARIFF & REGULATORY LANDSCAPE	104
5.10.1	REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS	104
TABLE 9	NORTH AMERICA: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS	104
TABLE 10	EUROPE: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS	105
TABLE 11	ASIA PACIFIC: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS	106
TABLE 12	REGULATORY STANDARDS IN TELEHEALTH & TELEMEDICINE MARKET	107
5.10.2	REGULATORY ANALYSIS	108
TABLE 13	REGULATORY REQUIREMENTS IN NORTH AMERICA	108
TABLE 14	REGULATORY REQUIREMENTS IN EUROPE	109
TABLE 15	REGULATORY REQUIREMENTS IN ASIA PACIFIC	109
TABLE 16	REGULATORY REQUIREMENTS IN LATIN AMERICA	110
TABLE 17	REGULATORY REQUIREMENTS IN MIDDLE EAST & AFRICA	110
5.11	TRADE ANALYSIS	111
5.11.1	TRADE ANALYSIS FOR TELEHEALTH & TELEMEDICINE DEVICES	111
FIGURE 26	IMPORTS OF PRODUCTS UNDER HSN CODE 90189099, BY COUNTRY, 2022 (USD THOUSAND)	111
FIGURE 27	EXPORTS OF PRODUCTS UNDER HSN CODE 90189099, BY COUNTRY, 2022 (USD THOUSAND)	112
5.12	PRICING ANALYSIS	112
5.12.1	COSTS INVOLVED IN TELEMEDICINE DEVICES	112
5.12.2	AVERAGE SELLING PRICE FOR TELEHEALTH & TELEMEDICINE DEVICES, BY KEY PLAYER	113
5.12.3	INDICATIVE PRICING ANALYSIS OF TELEHEALTH & TELEMEDICINE DEVICES, BY REGION	113
5.12.4	PRICING MODELS	113
5.13	REIMBURSEMENT ANALYSIS	114
5.13.1	TYPES OF VIRTUAL SERVICES TO MEDICARE BENEFICIARIES	114
TABLE 18	MEDICARE TELEMEDICINE SERVICES AND HCPCS/CPT CODES	114
5.14	INVESTMENT LANDSCAPE	115
FIGURE 28	INVESTOR DEALS AND FUNDING IN TELEHEALTH & TELEMEDICINE DROPPED IN 2022	115
FIGURE 29	TOP FUNDED GLOBAL DIGITAL HEALTH CATEGORIES IN 2021	116
FIGURE 30	MOST VALUED TELEHEALTH & TELEMEDICINE FIRMS IN 2022 (USD BILLION)	117
5.15	KEY CONFERENCES & EVENTS	117
TABLE 19	LIST OF KEY CONFERENCES & EVENTS, 2023–2024	117
5.16	TRENDS/DISRUPTIONS IMPACTING CUSTOMERS’ BUSINESSES	118
FIGURE 31	REVENUE SHIFT IN TELEHEALTH & TELEMEDICINE MARKET	118
5.17	KEY STAKEHOLDERS & BUYING CRITERIA	119
5.17.1	KEY STAKEHOLDERS	119
FIGURE 32	INFLUENCE OF STAKEHOLDERS ON BUYING PROCESS	119
TABLE 20	INFLUENCE OF STAKEHOLDERS ON BUYING PROCESS (%)	119
5.17.2	BUYING CRITERIA	120
FIGURE 33	KEY BUYING CRITERIA	120
TABLE 21	KEY BUYING CRITERIA FOR TELEHEALTH & TELEMEDICINE MARKET	120
5.18	UNMET NEEDS	121
TABLE 22	UNMET NEED IN TELEHEALTH & TELEMEDICINE MARKET	121
6	TELEHEALTH & TELEMEDICINE MARKET, BY COMPONENT	123
6.1	INTRODUCTION	124
TABLE 23	TELEHEALTH & TELEMEDICINE MARKET, BY COMPONENT, 2021–2028 (USD MILLION)	124
6.2	SOFTWARE & SERVICES	124
TABLE 24	TELEHEALTH & TELEMEDICINE MARKET FOR SOFTWARE & SERVICES, BY REGION, 2021–2028 (USD MILLION)	124
TABLE 25	NORTH AMERICA: TELEHEALTH & TELEMEDICINE MARKET FOR SOFTWARE & SERVICES, BY COUNTRY, 2021–2028 (USD MILLION)	125
TABLE 26	EUROPE: TELEHEALTH & TELEMEDICINE MARKET FOR SOFTWARE & SERVICES, BY COUNTRY, 2021–2028 (USD MILLION)	125
TABLE 27	ASIA PACIFIC: TELEHEALTH & TELEMEDICINE MARKET FOR SOFTWARE & SERVICES, BY COUNTRY, 2021–2028 (USD MILLION)	126
TABLE 28	LATIN AMERICA: TELEHEALTH & TELEMEDICINE MARKET FOR SOFTWARE & SERVICES, BY COUNTRY, 2021–2028 (USD MILLION)	126
TABLE 29	MIDDLE EAST & AFRICA: TELEHEALTH & TELEMEDICINE MARKET FOR SOFTWARE & SERVICES, BY COUNTRY, 2021–2028 (USD MILLION)	126
TABLE 30	TELEHEALTH & TELEMEDICINE MARKET FOR SOFTWARE & SERVICES, BY TYPE, 2021–2028 (USD MILLION)	127
6.2.1	SOFTWARE & SERVICES, BY TYPE	127
6.2.1.1	Remote patient monitoring	127
6.2.1.1.1	Convenience of tracking patient vitals from different places to drive segment	127
TABLE 31	REMOTE PATIENT MONITORING MARKET, BY REGION,
2021–2028 (USD MILLION)	129
6.2.1.2	Real-time interaction	129
6.2.1.2.1	Synchronous nature and potential for better healthcare access to drive segment	129
TABLE 32	REAL-TIME INTERACTION MARKET, BY REGION, 2021–2028 (USD MILLION)	130
6.2.1.3	Store and forward	130
6.2.1.3.1	Easy monitoring of vital signs for long-term chronic care without physical presence to drive segment	130
TABLE 33	STORE AND FORWARD MARKET, BY REGION, 2021–2028 (USD MILLION)	131
6.2.2	SOFTWARE & SERVICES, BY REVENUE MODEL	131
TABLE 34	TELEHEALTH & TELEMEDICINE MARKET FOR SOFTWARE & SERVICES, BY REVENUE MODEL, 2021–2028 (USD MILLION)	131
6.2.2.1	One-time purchase	132
6.2.2.1.1	Increasing government funding and collaborations with healthcare organizations in rural areas to drive segment	132
TABLE 35	ONE-TIME PURCHASE MARKET, BY REGION, 2021–2028 (USD MILLION)	132
6.2.2.2	Subscription-based	133
6.2.2.2.1	Technological advancements and fixed recurring fees for telehealth consultations to drive segment	133
TABLE 36	SUBSCRIPTION-BASED MARKET, BY REGION, 2021–2028 (USD MILLION)	133
6.2.2.3	Pay-per-use	133
6.2.2.3.1	Lack of adequate reimbursement policies to limit segment	133
TABLE 37	PAY-PER-USE MARKET, BY REGION, 2021–2028 (USD MILLION)	134
6.3	HARDWARE	134
TABLE 38	TELEHEALTH & TELEMEDICINE MARKET FOR HARDWARE, BY REGION, 2021–2028 (USD MILLION)	134
TABLE 39	NORTH AMERICA: TELEHEALTH & TELEMEDICINE MARKET FOR HARDWARE, BY COUNTRY, 2021–2028 (USD MILLION)	135
TABLE 40	EUROPE: TELEHEALTH & TELEMEDICINE MARKET FOR HARDWARE, BY COUNTRY, 2021–2028 (USD MILLION)	135
TABLE 41	ASIA PACIFIC: TELEHEALTH & TELEMEDICINE MARKET FOR HARDWARE, BY COUNTRY, 2021–2028 (USD MILLION)	136
TABLE 42	LATIN AMERICA: TELEHEALTH & TELEMEDICINE MARKET FOR HARDWARE, BY REGION, 2021–2028 (USD MILLION)	136
TABLE 43	MIDDLE EAST & AFRICA: TELEHEALTH & TELEMEDICINE MARKET FOR HARDWARE, BY COUNTRY, 2021–2028 (USD MILLION)	136
TABLE 44	TELEHEALTH & TELEMEDICINE MARKET FOR HARDWARE, BY TYPE, 2021–2028 (USD MILLION)	137
6.3.1	MONITORS	137
6.3.1.1	Increase in remote monitoring and rising adoption of telemedicine devices to drive segment	137
TABLE 45	MONITORS MARKET, BY REGION, 2021–2028 (USD MILLION)	137
6.3.2	MEDICAL PERIPHERAL DEVICES	138
TABLE 46	MEDICAL PERIPHERAL DEVICES MARKET, BY TYPE, 2021–2028 (USD MILLION)	138
TABLE 47	MEDICAL PERIPHERAL DEVICES MARKET, BY REGION, 2021–2028 (USD MILLION)	139
6.3.2.1	Blood pressure monitors	139
6.3.2.1.1	Increasing prevalence of hypertension and obesity to drive segment	139
TABLE 48	BLOOD PRESSURE MONITORS MARKET, BY REGION, 2021–2028 (USD MILLION)	140
6.3.2.2	Blood glucose meters	140
6.3.2.2.1	Growth in diabetic population to drive segment	140
TABLE 49	BLOOD GLUCOSE METERS MARKET, BY REGION, 2021–2028 (USD MILLION)	141
6.3.2.3	Weight scales	141
6.3.2.3.1	Increasing prevalence of obesity to drive segment	141
TABLE 50	WEIGHT SCALES MARKET, BY REGION, 2021–2028 (USD MILLION)	142
6.3.2.4	Pulse oximeters	142
6.3.2.4.1	Rising awareness about self-monitoring and ease of usage to drive segment	142
TABLE 51	PULSE OXIMETER MARKET, BY REGION, 2021–2028 (USD MILLION)	142
6.3.2.5	Peak flow meters	143
6.3.2.5.1	Rapid assessment of lung conditions and growth in respiratory complications to drive segment	143
TABLE 52	PEAK FLOW METERS MARKET, BY REGION, 2021–2028 (USD MILLION)	143
6.3.2.6	ECG monitors	143
6.3.2.6.1	Rising incidence of cardiovascular diseases to drive segment	143
TABLE 53	ECG MONITORS MARKET, BY REGION, 2021–2028 (USD MILLION)	144
6.3.2.7	Other medical peripheral devices	144
TABLE 54	OTHER MEDICAL PERIPHERAL PRODUCTS OFFERED BY KEY PLAYERS	144
TABLE 55	OTHER MEDICAL PERIPHERAL DEVICES MARKET, BY REGION, 2021–2028 (USD MILLION)	145
7	TELEHEALTH & TELEMEDICINE MARKET, BY MODE OF DELIVERY	146
7.1	INTRODUCTION	147
TABLE 56	TELEHEALTH & TELEMEDICINE MARKET, BY MODE OF DELIVERY, 2021–2028 (USD MILLION)	147
7.2	CLOUD-BASED DELIVERY	147
7.2.1	CLOUD-BASED DELIVERY SEGMENT TO DOMINATE MARKET DURING FORECAST PERIOD	147
TABLE 57	TELEHEALTH & TELEMEDICINE MARKET FOR CLOUD-BASED DELIVERY, BY REGION, 2021–2028 (USD MILLION)	148
TABLE 58	NORTH AMERICA: TELEHEALTH & TELEMEDICINE MARKET FOR CLOUD-BASED DELIVERY, BY COUNTRY, 2021–2028 (USD MILLION)	148
TABLE 59	EUROPE: TELEHEALTH & TELEMEDICINE MARKET FOR CLOUD-BASED DELIVERY, BY COUNTRY, 2021–2028 (USD MILLION)	149
TABLE 60	ASIA PACIFIC: TELEHEALTH & TELEMEDICINE MARKET FOR CLOUD-BASED DELIVERY, BY COUNTRY, 2021–2028 (USD MILLION)	149
TABLE 61	LATIN AMERICA: TELEHEALTH & TELEMEDICINE MARKET FOR CLOUD-BASED DELIVERY, BY COUNTRY, 2021–2028 (USD MILLION)	150
TABLE 62	MIDDLE EAST & AFRICA: TELEHEALTH & TELEMEDICINE MARKET FOR CLOUD-BASED DELIVERY, BY COUNTRY, 2021–2028 (USD MILLION)	150
7.3	ON-PREMISE DELIVERY	150
7.3.1	ENHANCED CONTROL OF SOFTWARE AND EASY REUSE OF EXISTING INFRASTRUCTURE TO DRIVE MARKET	150
TABLE 63	TELEHEALTH & TELEMEDICINE MARKET FOR ON-PREMISE DELIVERY, BY REGION, 2021–2028 (USD MILLION)	151
TABLE 64	NORTH AMERICA: TELEHEALTH & TELEMEDICINE MARKET FOR ON-PREMISE DELIVERY, BY COUNTRY, 2021–2028 (USD MILLION)	151
TABLE 65	EUROPE: TELEHEALTH & TELEMEDICINE MARKET FOR ON-PREMISE DELIVERY, BY COUNTRY, 2021–2028 (USD MILLION)	152
TABLE 66	ASIA PACIFIC: TELEHEALTH & TELEMEDICINE MARKET FOR ON-PREMISE DELIVERY, BY COUNTRY, 2021–2028 (USD MILLION)	152
TABLE 67	LATIN AMERICA: TELEHEALTH & TELEMEDICINE MARKET FOR ON-PREMISE DELIVERY, BY COUNTRY, 2021–2028 (USD MILLION)	153
TABLE 68	MIDDLE EAST & AFRICA: TELEHEALTH & TELEMEDICINE MARKET FOR ON-PREMISE DELIVERY, BY COUNTRY, 2021–2028 (USD MILLION)	153
8	TELEHEALTH & TELEMEDICINE MARKET, BY APPLICATION	154
8.1	INTRODUCTION	155
TABLE 69	TELEHEALTH & TELEMEDICINE MARKET, BY APPLICATION, 2021–2028 (USD MILLION)	155
8.2	TELECONSULTATION	155
8.2.1	INCREASED NEED FOR AT-HOME FACILITIES AND SHORTAGE OF MEDICAL STAFF TO DRIVE MARKET	155
TABLE 70	TELEHEALTH & TELEMEDICINE MARKET FOR TELECONSULTATION, BY REGION, 2021–2028 (USD MILLION)	156
TABLE 71	NORTH AMERICA: TELEHEALTH & TELEMEDICINE MARKET FOR TELECONSULTATION, BY COUNTRY, 2021–2028 (USD MILLION)	156
TABLE 72	EUROPE: TELEHEALTH & TELEMEDICINE MARKET FOR TELECONSULTATION, BY COUNTRY, 2021–2028 (USD MILLION)	157
TABLE 73	ASIA PACIFIC: TELEHEALTH & TELEMEDICINE MARKET FOR TELECONSULTATION, BY COUNTRY, 2021–2028 (USD MILLION)	157
TABLE 74	LATIN AMERICA: TELEHEALTH & TELEMEDICINE MARKET FOR TELECONSULTATION, BY COUNTRY, 2021–2028 (USD MILLION)	158
TABLE 75	MIDDLE EAST & AFRICA: TELEHEALTH & TELEMEDICINE MARKET FOR TELECONSULTATION, BY COUNTRY, 2021–2028 (USD MILLION)	158
8.3	TELEICU	158
8.3.1	INCREASING NUMBER OF PATIENTS IN EMERGENCY DEPARTMENTS AND STAFF SHORTAGE IN RURAL AREAS TO DRIVE MARKET	158
TABLE 76	TELEHEALTH & TELEMEDICINE MARKET FOR TELEICU, BY REGION, 2021–2028 (USD MILLION)	159
TABLE 77	NORTH AMERICA: TELEHEALTH & TELEMEDICINE MARKET FOR TELEICU, BY COUNTRY, 2021–2028 (USD MILLION)	160
TABLE 78	EUROPE: TELEHEALTH & TELEMEDICINE MARKET FOR TELEICU, BY COUNTRY, 2021–2028 (USD MILLION)	160
TABLE 79	ASIA PACIFIC: TELEHEALTH & TELEMEDICINE MARKET FOR TELEICU, BY COUNTRY, 2021–2028 (USD MILLION)	161
TABLE 80	LATIN AMERICA: TELEHEALTH & TELEMEDICINE MARKET FOR TELEICU, BY COUNTRY, 2021–2028 (USD MILLION)	161
TABLE 81	MIDDLE EAST & AFRICA: TELEHEALTH & TELEMEDICINE MARKET FOR TELEICU, BY COUNTRY, 2021–2028 (USD MILLION)	161
8.4	TELEPSYCHIATRY	162
8.4.1	SHORTAGE OF MENTAL HEALTH PRACTITIONERS AND FAVORABLE REIMBURSEMENT SCENARIO TO DRIVE MARKET	162
TABLE 82	TELEHEALTH & TELEMEDICINE MARKET FOR TELEPSYCHIATRY, BY REGION, 2021–2028 (USD MILLION)	163
TABLE 83	NORTH AMERICA: TELEHEALTH & TELEMEDICINE MARKET FOR TELEPSYCHIATRY, BY COUNTRY, 2021–2028 (USD MILLION)	163
TABLE 84	EUROPE: TELEHEALTH & TELEMEDICINE MARKET FOR TELEPSYCHIATRY, BY COUNTRY, 2021–2028 (USD MILLION)	164
TABLE 85	ASIA PACIFIC: TELEHEALTH & TELEMEDICINE MARKET FOR TELEPSYCHIATRY, BY COUNTRY, 2021–2028 (USD MILLION)	164
TABLE 86	LATIN AMERICA: TELEHEALTH & TELEMEDICINE MARKET FOR TELEPSYCHIATRY, BY COUNTRY, 2021–2028 (USD MILLION)	165
TABLE 87	MIDDLE EAST & AFRICA: TELEHEALTH & TELEMEDICINE MARKET FOR TELEPSYCHIATRY, BY COUNTRY, 2021–2028 (USD MILLION)	165
8.5	TELERADIOLOGY	165
8.5.1	TELERADIOLOGY TO ACCOUNT FOR LARGEST MARKET SHARE DURING FORECAST PERIOD	165
TABLE 88	TELEHEALTH & TELEMEDICINE MARKET FOR TELERADIOLOGY, BY REGION, 2021–2028 (USD MILLION)	166
TABLE 89	NORTH AMERICA: TELEHEALTH & TELEMEDICINE MARKET FOR TELERADIOLOGY, BY COUNTRY, 2021–2028 (USD MILLION)	167
TABLE 90	EUROPE: TELEHEALTH & TELEMEDICINE MARKET FOR TELERADIOLOGY, BY COUNTRY, 2021–2028 (USD MILLION)	167
TABLE 91	ASIA PACIFIC: TELEHEALTH & TELEMEDICINE MARKET FOR TELERADIOLOGY, BY COUNTRY, 2021–2028 (USD MILLION)	168
TABLE 92	LATIN AMERICA: TELEHEALTH & TELEMEDICINE MARKET FOR TELERADIOLOGY, BY COUNTRY, 2021–2028 (USD MILLION)	168
TABLE 93	MIDDLE EAST & AFRICA: TELEHEALTH & TELEMEDICINE MARKET FOR TELERADIOLOGY, BY COUNTRY, 2021–2028 (USD MILLION)	168
8.6	TELESTROKE	169
8.6.1	RISING INCIDENCE OF STROKE AND INCREASING GERIATRIC POPULATION TO DRIVE MARKET	169
TABLE 94	TELEHEALTH & TELEMEDICINE MARKET FOR TELESTROKE, BY REGION, 2021–2028 (USD MILLION)	169
TABLE 95	NORTH AMERICA: TELEHEALTH & TELEMEDICINE MARKET FOR TELESTROKE, BY COUNTRY, 2021–2028 (USD MILLION)	169
TABLE 96	EUROPE: TELEHEALTH & TELEMEDICINE MARKET FOR TELESTROKE, BY COUNTRY, 2021–2028 (USD MILLION)	170
TABLE 97	ASIA PACIFIC: TELEHEALTH & TELEMEDICINE MARKET FOR TELESTROKE, BY COUNTRY, 2021–2028 (USD MILLION)	170
TABLE 98	LATIN AMERICA: TELEHEALTH & TELEMEDICINE MARKET FOR TELESTROKE, BY COUNTRY, 2021–2028 (USD MILLION)	171
TABLE 99	MIDDLE EAST & AFRICA: TELEHEALTH & TELEMEDICINE MARKET FOR TELESTROKE, BY COUNTRY, 2021–2028 (USD MILLION)	171
 
8.7	TELEDERMATOLOGY	171
8.7.1	RISING PREVALENCE OF SKIN DISEASES AND GROWING USE OF HD CAMERAS FOR SKIN DIAGNOSIS TO DRIVE MARKET	171
TABLE 100	TELEHEALTH & TELEMEDICINE MARKET FOR TELEDERMATOLOGY, BY REGION, 2021–2028 (USD MILLION)	172
TABLE 101	NORTH AMERICA: TELEHEALTH & TELEMEDICINE MARKET FOR TELEDERMATOLOGY, BY COUNTRY, 2021–2028 (USD MILLION)	172
TABLE 102	EUROPE: TELEHEALTH & TELEMEDICINE MARKET FOR TELEDERMATOLOGY, BY COUNTRY, 2021–2028 (USD MILLION)	173
TABLE 103	ASIA PACIFIC: TELEHEALTH & TELEMEDICINE MARKET FOR TELEDERMATOLOGY, BY COUNTRY, 2021–2028 (USD MILLION)	173
TABLE 104	LATIN AMERICA: TELEHEALTH & TELEMEDICINE MARKET FOR TELEDERMATOLOGY, BY COUNTRY, 2021–2028 (USD MILLION)	174
TABLE 105	MIDDLE EAST & AFRICA: TELEHEALTH & TELEMEDICINE MARKET FOR TELEDERMATOLOGY, BY COUNTRY, 2021–2028 (USD MILLION)	174
8.8	OTHER APPLICATIONS	175
TABLE 106	TELEHEALTH & TELEMEDICINE MARKET FOR OTHER APPLICATIONS, BY REGION, 2021–2028 (USD MILLION)	175
TABLE 107	NORTH AMERICA: TELEHEALTH & TELEMEDICINE MARKET FOR OTHER APPLICATIONS, BY COUNTRY, 2021–2028 (USD MILLION)	175
TABLE 108	EUROPE: TELEHEALTH & TELEMEDICINE MARKET FOR OTHER APPLICATIONS, BY COUNTRY, 2021–2028 (USD MILLION)	176
TABLE 109	ASIA PACIFIC: TELEHEALTH & TELEMEDICINE MARKET FOR OTHER APPLICATIONS, BY COUNTRY, 2021–2028 (USD MILLION)	176
TABLE 110	LATIN AMERICA: TELEHEALTH & TELEMEDICINE MARKET FOR OTHER APPLICATIONS, BY COUNTRY, 2021–2028 (USD MILLION)	177
TABLE 111	MIDDLE EAST & AFRICA: TELEHEALTH & TELEMEDICINE MARKET FOR OTHER APPLICATIONS, BY COUNTRY, 2021–2028 (USD MILLION)	177
9	TELEHEALTH & TELEMEDICINE MARKET, BY END USER	178
9.1	INTRODUCTION	179
TABLE 112	TELEHEALTH & TELEMEDICINE MARKET, BY END USER, 2021–2028 (USD MILLION)	179
9.2	PROVIDERS	179
TABLE 113	TELEHEALTH & TELEMEDICINE MARKET FOR PROVIDERS, BY TYPE, 2021–2028 (USD MILLION)	180
TABLE 114	TELEHEALTH & TELEMEDICINE MARKET FOR PROVIDERS, BY REGION, 2021–2028 (USD MILLION)	180
TABLE 115	NORTH AMERICA: TELEHEALTH & TELEMEDICINE MARKET FOR PROVIDERS, BY COUNTRY, 2021–2028 (USD MILLION)	180
TABLE 116	EUROPE: TELEHEALTH & TELEMEDICINE MARKET FOR PROVIDERS, BY COUNTRY, 2021–2028 (USD MILLION)	181
TABLE 117	ASIA PACIFIC: TELEHEALTH & TELEMEDICINE MARKET FOR PROVIDERS, BY COUNTRY, 2021–2028 (USD MILLION)	181
TABLE 118	LATIN AMERICA: TELEHEALTH & TELEMEDICINE MARKET FOR PROVIDERS, BY REGION, 2021–2028 (USD MILLION)	182
TABLE 119	MIDDLE EAST & AFRICA: TELEHEALTH & TELEMEDICINE MARKET FOR PROVIDERS, BY COUNTRY, 2021–2028 (USD MILLION)	182
9.2.1	HOSPITALS & CLINICS	182
9.2.1.1	Growing incidence of chronic diseases and rising demand for high-quality care to drive segment	182
TABLE 120	HOSPITALS & CLINICS MARKET, BY REGION, 2021–2028 (USD MILLION)	183
9.2.2	LONG-TERM CARE CENTERS AND ASSISTED LIVING FACILITIES	183
9.2.2.1	Increasing geriatric population and rising need for prolonged treatment for chronic diseases to drive segment	183
TABLE 121	LONG-TERM CARE CENTERS AND ASSISTED LIVING FACILITIES MARKET, BY REGION, 2021–2028 (USD MILLION)	184
9.3	PAYERS	184
TABLE 122	TELEHEALTH & TELEMEDICINE MARKET FOR PAYERS, BY TYPE 2021–2028 (USD MILLION)	185
TABLE 123	TELEHEALTH & TELEMEDICINE MARKET FOR PAYERS, BY REGION, 2021–2028 (USD MILLION)	185
TABLE 124	NORTH AMERICA: TELEHEALTH & TELEMEDICINE MARKET FOR PAYERS, BY COUNTRY, 2021–2028 (USD MILLION)	185
TABLE 125	EUROPE: TELEHEALTH & TELEMEDICINE MARKET FOR PAYERS, BY COUNTRY, 2021–2028 (USD MILLION)	186
TABLE 126	ASIA PACIFIC: TELEHEALTH & TELEMEDICINE MARKET FOR PAYERS, BY COUNTRY, 2021–2028 (USD MILLION)	186
TABLE 127	LATIN AMERICA: TELEHEALTH & TELEMEDICINE MARKET FOR PAYERS, BY COUNTRY, 2021–2028 (USD MILLION)	187
TABLE 128	MIDDLE EAST & AFRICA: TELEHEALTH & TELEMEDICINE MARKET FOR PAYERS, BY COUNTRY, 2021–2028 (USD MILLION)	187
9.3.1	PUBLIC PAYERS	187
9.3.1.1	Increasing investments by public payers to drive segment	187
TABLE 129	PUBLIC PAYERS MARKET, BY REGION, 2021–2028 (USD MILLION)	188
9.3.2	PRIVATE PAYERS	188
9.3.2.1	Expansion of telehealth services to mental health and substance usage to drive segment	188
TABLE 130	PRIVATE PAYERS MARKET, BY REGION, 2021–2028 (USD MILLION)	189
9.4	PATIENTS	189
9.4.1	RISING PREVALENCE OF CHRONIC DISEASES AND EMERGENCE OF ADVANCED WEARABLE MONITORS TO DRIVE MARKET	189
TABLE 131	TELEHEALTH & TELEMEDICINE MARKET FOR PATIENTS, BY REGION, 2021–2028 (USD MILLION)	190
TABLE 132	NORTH AMERICA: TELEHEALTH & TELEMEDICINE MARKET FOR PATIENTS, BY COUNTRY, 2021–2028 (USD MILLION)	190
TABLE 133	EUROPE: TELEHEALTH & TELEMEDICINE MARKET FOR PATIENTS, BY COUNTRY, 2021–2028 (USD MILLION)	191
TABLE 134	ASIA PACIFIC: TELEHEALTH & TELEMEDICINE MARKET FOR PATIENTS, BY COUNTRY, 2021–2028 (USD MILLION)	191
TABLE 135	LATIN AMERICA: TELEHEALTH & TELEMEDICINE MARKET FOR PATIENTS, BY COUNTRY, 2021–2028 (USD MILLION)	192
TABLE 136	MIDDLE EAST & AFRICA: TELEHEALTH & TELEMEDICINE MARKET FOR PATIENTS, BY COUNTRY, 2021–2028 (USD MILLION)	192
 
9.5	OTHER END USERS	192
TABLE 137	TELEHEALTH & TELEMEDICINE MARKET FOR OTHER END USERS, BY REGION, 2021–2028 (USD MILLION)	193
TABLE 138	NORTH AMERICA: TELEHEALTH & TELEMEDICINE MARKET FOR OTHER END USERS, BY COUNTRY, 2021–2028 (USD MILLION)	193
TABLE 139	EUROPE: TELEHEALTH & TELEMEDICINE MARKET FOR OTHER END USERS, BY COUNTRY, 2021–2028 (USD MILLION)	194
TABLE 140	ASIA PACIFIC: TELEHEALTH & TELEMEDICINE MARKET FOR OTHER END USERS, BY COUNTRY, 2021–2028 (USD MILLION)	194
TABLE 141	LATIN AMERICA: TELEHEALTH & TELEMEDICINE MARKET FOR OTHER END USERS, BY COUNTRY, 2021–2028 (USD MILLION)	195
TABLE 142	MIDDLE EAST & AFRICA: TELEHEALTH & TELEMEDICINE MARKET FOR OTHER END USERS, BY COUNTRY, 2021–2028 (USD MILLION)	195
10	TELEHEALTH & TELEMEDICINE MARKET, BY REGION	196
10.1	INTRODUCTION	197
FIGURE 34	GEOGRAPHIC SNAPSHOT: TELEHEALTH & TELEMEDICINE MARKET, 2022	197
TABLE 143	TELEHEALTH & TELEMEDICINE MARKET, BY REGION, 2021–2028 (USD MILLION)	198
10.2	NORTH AMERICA	198
FIGURE 35	NORTH AMERICA: TELEHEALTH & TELEMEDICINE MARKET SNAPSHOT	199
TABLE 144	NORTH AMERICA: TELEHEALTH & TELEMEDICINE MARKET, BY COUNTRY, 2021–2028 (USD MILLION)	200
TABLE 145	NORTH AMERICA: TELEHEALTH & TELEMEDICINE MARKET, BY COMPONENT, 2021–2028 (USD MILLION)	200
TABLE 146	NORTH AMERICA: TELEHEALTH & TELEMEDICINE MARKET FOR SOFTWARE & SERVICES, BY TYPE, 2021–2028 (USD MILLION)	200
TABLE 147	NORTH AMERICA: TELEHEALTH & TELEMEDICINE MARKET FOR SOFTWARE & SERVICES, BY REVENUE MODEL, 2021–2028 (USD MILLION)	201
TABLE 148	NORTH AMERICA: TELEHEALTH & TELEMEDICINE MARKET FOR HARDWARE, BY TYPE, 2021–2028 (USD MILLION)	201
TABLE 149	NORTH AMERICA: TELEHEALTH & TELEMEDICINE HARDWARE MARKET, BY TYPE, 2021–2028 (USD MILLION)	202
TABLE 150	NORTH AMERICA: TELEHEALTH & TELEMEDICINE MARKET, BY MODE OF DELIVERY, 2021–2028 (USD MILLION)	202
TABLE 151	NORTH AMERICA: TELEHEALTH & TELEMEDICINE MARKET, BY APPLICATION, 2021–2028 (USD MILLION)	203
TABLE 152	NORTH AMERICA: TELEHEALTH & TELEMEDICINE MARKET, BY END USER, 2021–2028 (USD MILLION)	203
TABLE 153	NORTH AMERICA: TELEHEALTH & TELEMEDICINE MARKET FOR PROVIDERS, BY TYPE 2021–2028 (USD MILLION)	204
TABLE 154	NORTH AMERICA: TELEHEALTH & TELEMEDICINE MARKET FOR PAYERS, BY TYPE 2021–2028 (USD MILLION)	204
10.2.1	NORTH AMERICA: RECESSION IMPACT	204
10.2.2	US	205
10.2.2.1	US to dominate North American market during forecast period	205
TABLE 155	US: TELEHEALTH & TELEMEDICINE MARKET, BY COMPONENT, 2021–2028 (USD MILLION)	207
TABLE 156	US: TELEHEALTH & TELEMEDICINE MARKET FOR SOFTWARE & SERVICES, BY TYPE, 2021–2028 (USD MILLION)	207
TABLE 157	US: TELEHEALTH & TELEMEDICINE MARKET FOR SOFTWARE & SERVICES, BY REVENUE MODEL, 2021–2028 (USD MILLION)	207
TABLE 158	US: TELEHEALTH & TELEMEDICINE MARKET FOR HARDWARE, BY TYPE, 2021–2028 (USD MILLION)	208
TABLE 159	US: MEDICAL PERIPHERAL DEVICES MARKET, BY TYPE, 2021–2028 (USD MILLION)	208
TABLE 160	US: TELEHEALTH & TELEMEDICINE MARKET, BY MODE OF DELIVERY, 2021–2028 (USD MILLION)	209
TABLE 161	US: TELEHEALTH & TELEMEDICINE MARKET, BY APPLICATION, 2021–2028 (USD MILLION)	209
TABLE 162	US: TELEHEALTH & TELEMEDICINE MARKET, BY END USER, 2021–2028 (USD MILLION)	210
TABLE 163	US: TELEHEALTH & TELEMEDICINE MARKET FOR PROVIDERS, BY TYPE 2021–2028 (USD MILLION)	210
TABLE 164	US: TELEHEALTH & TELEMEDICINE MARKET FOR PAYERS, BY TYPE 2021–2028 (USD MILLION)	210
10.2.3	CANADA	211
10.2.3.1	Increasing geriatric population and rising government healthcare expenditure to drive market	211
TABLE 165	CANADA: TELEHEALTH & TELEMEDICINE MARKET, BY COMPONENT, 2021–2028 (USD MILLION)	212
TABLE 166	CANADA: TELEHEALTH & TELEMEDICINE MARKET FOR SOFTWARE & SERVICES, BY TYPE, 2021–2028 (USD MILLION)	212
TABLE 167	CANADA: TELEHEALTH & TELEMEDICINE MARKET FOR SOFTWARE & SERVICES, BY REVENUE MODEL, 2021–2028 (USD MILLION)	212
TABLE 168	CANADA: TELEHEALTH & TELEMEDICINE MARKET FOR HARDWARE, BY TYPE, 2021–2028 (USD MILLION)	213
TABLE 169	CANADA: MEDICAL PERIPHERAL DEVICES MARKET, BY TYPE, 2021–2028 (USD MILLION)	213
TABLE 170	CANADA: TELEHEALTH & TELEMEDICINE MARKET, BY MODE OF DELIVERY, 2021–2028 (USD MILLION)	213
TABLE 171	CANADA: TELEHEALTH & TELEMEDICINE MARKET, BY APPLICATION, 2021–2028 (USD MILLION)	214
TABLE 172	CANADA: TELEHEALTH & TELEMEDICINE MARKET, BY END USER, 2021–2028 (USD MILLION)	214
TABLE 173	CANADA: TELEHEALTH & TELEMEDICINE MARKET FOR PROVIDERS, BY TYPE 2021–2028 (USD MILLION)	215
TABLE 174	CANADA: TELEHEALTH & TELEMEDICINE MARKET FOR PAYERS, BY TYPE 2021–2028 (USD MILLION)	215
TABLE 175 EUROPE: TELEHEALTH & TELEMEDICINE MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 216
TABLE 176 EUROPE: TELEHEALTH & TELEMEDICINE MARKET, BY COMPONENT, 2021–2028 (USD MILLION) 216
TABLE 177 EUROPE: TELEHEALTH & TELEMEDICINE MARKET FOR SOFTWARE & SERVICES, BY TYPE, 2021–2028 (USD MILLION) 217
TABLE 178 EUROPE: TELEHEALTH & TELEMEDICINE MARKET FOR SOFTWARE & SERVICES, BY REVENUE MODEL, 2021–2028 (USD MILLION) 217
TABLE 179 EUROPE: TELEHEALTH & TELEMEDICINE MARKET FOR HARDWARE, BY TYPE, 2021–2028 (USD MILLION) 217
TABLE 180 EUROPE: MEDICAL PERIPHERAL DEVICES MARKET, BY TYPE, 2021–2028 (USD MILLION) 218
TABLE 181 EUROPE: TELEHEALTH & TELEMEDICINE MARKET, BY MODE OF DELIVERY, 2021–2028 (USD MILLION) 218
TABLE 182 EUROPE: TELEHEALTH & TELEMEDICINE MARKET, BY APPLICATION, 2021–2028 (USD MILLION) 219
TABLE 183 EUROPE: TELEHEALTH & TELEMEDICINE MARKET, BY END USER, 2021–2028 (USD MILLION) 219
TABLE 184 EUROPE: TELEHEALTH & TELEMEDICINE MARKET FOR PROVIDERS, BY TYPE 2021–2028 (USD MILLION) 220
TABLE 185 EUROPE: TELEHEALTH & TELEMEDICINE MARKET FOR PAYERS, BY TYPE 2021–2028 (USD MILLION) 220
10.3.1 EUROPE: RECESSION IMPACT 220
10.3.2 GERMANY 221
10.3.2.1 Rapid digitization of healthcare systems and repealed ban on remote treatment to drive market 221
TABLE 186 GERMANY: TELEHEALTH & TELEMEDICINE MARKET, BY COMPONENT, 2021–2028 (USD MILLION) 222
TABLE 187 GERMANY: TELEHEALTH & TELEMEDICINE MARKET FOR SOFTWARE & SERVICES, BY TYPE, 2021–2028 (USD MILLION) 222
TABLE 188 GERMANY: TELEHEALTH & TELEMEDICINE MARKET FOR SOFTWARE & SERVICES, BY REVENUE MODEL, 2021–2028 (USD MILLION) 222
TABLE 189 GERMANY: TELEHEALTH & TELEMEDICINE MARKET FOR HARDWARE, BY TYPE, 2021–2028 (USD MILLION) 223
TABLE 190 GERMANY: MEDICAL PERIPHERAL DEVICES MARKET, BY TYPE, 2021–2028 (USD MILLION) 223
TABLE 191 GERMANY: TELEHEALTH & TELEMEDICINE MARKET, BY MODE OF DELIVERY, 2021–2028 (USD MILLION) 223
TABLE 192 GERMANY: TELEHEALTH & TELEMEDICINE MARKET, BY APPLICATION, 2021–2028 (USD MILLION) 224
TABLE 193 GERMANY: TELEHEALTH & TELEMEDICINE MARKET, BY END USER, 2021–2028 (USD MILLION) 224
TABLE 194 GERMANY: TELEHEALTH & TELEMEDICINE MARKET FOR PROVIDERS, BY TYPE 2021–2028 (USD MILLION) 225
TABLE 195 GERMANY: TELEHEALTH & TELEMEDICINE MARKET FOR PAYERS, BY TYPE 2021–2028 (USD MILLION) 225
10.3.3 FRANCE 225
10.3.3.1 Favorable reimbursement and investment scenario for remote healthcare services to drive market 225
TABLE 196 FRANCE: TELEHEALTH & TELEMEDICINE MARKET, BY COMPONENT, 2021–2028 (USD MILLION) 226
TABLE 197 FRANCE: TELEHEALTH & TELEMEDICINE MARKET FOR SOFTWARE & SERVICES, BY TYPE, 2021–2028 (USD MILLION) 226
TABLE 198 FRANCE: TELEHEALTH & TELEMEDICINE MARKET FOR SOFTWARE & SERVICES, BY REVENUE MODEL, 2021–2028 (USD MILLION) 227
TABLE 199 FRANCE: TELEHEALTH & TELEMEDICINE MARKET FOR HARDWARE, BY TYPE, 2021–2028 (USD MILLION) 227
TABLE 200 FRANCE: MEDICAL PERIPHERAL DEVICES MARKET, BY TYPE, 2021–2028 (USD MILLION) 227
TABLE 201 FRANCE: TELEHEALTH & TELEMEDICINE MARKET, BY MODE OF DELIVERY, 2021–2028 (USD MILLION) 228
TABLE 202 FRANCE: TELEHEALTH & TELEMEDICINE MARKET, BY APPLICATION, 2021–2028 (USD MILLION) 228
TABLE 203 FRANCE: TELEHEALTH & TELEMEDICINE MARKET, BY END USER, 2021–2028 (USD MILLION) 229
TABLE 204 FRANCE: TELEHEALTH & TELEMEDICINE MARKET FOR PROVIDERS, BY TYPE 2021–2028 (USD MILLION) 229
TABLE 205 FRANCE: TELEHEALTH & TELEMEDICINE MARKET FOR PAYERS, BY TYPE 2021–2028 (USD MILLION) 229
10.3.4 UK 230
10.3.4.1 Need to manage growing government healthcare expenditure and shortage of medical staff to drive market 230
TABLE 206 UK: TELEHEALTH & TELEMEDICINE MARKET, BY COMPONENT, 2021–2028 (USD MILLION) 230
TABLE 207 UK: TELEHEALTH & TELEMEDICINE MARKET FOR SOFTWARE & SERVICES, BY TYPE, 2021–2028 (USD MILLION) 231
TABLE 208 UK: TELEHEALTH & TELEMEDICINE MARKET FOR SOFTWARE & SERVICES, BY REVENUE MODEL, 2021–2028 (USD MILLION) 231
TABLE 209 UK: TELEHEALTH & TELEMEDICINE MARKET FOR HARDWARE, BY TYPE, 2021–2028 (USD MILLION) 231
TABLE 210 UK: MEDICAL PERIPHERAL DEVICES MARKET, BY TYPE, 2021–2028 (USD MILLION) 232
TABLE 211 UK: TELEHEALTH & TELEMEDICINE MARKET, BY MODE OF DELIVERY, 2021–2028 (USD MILLION) 232
TABLE 212 UK: TELEHEALTH & TELEMEDICINE MARKET, BY APPLICATION, 2021–2028 (USD MILLION) 233
TABLE 213 UK: TELEHEALTH & TELEMEDICINE MARKET, BY END USER, 2021–2028 (USD MILLION) 233
TABLE 214 UK: TELEHEALTH & TELEMEDICINE MARKET FOR PROVIDERS, BY TYPE 2021–2028 (USD MILLION) 234
TABLE 215 UK: TELEHEALTH & TELEMEDICINE MARKET FOR PAYERS, BY TYPE 2021–2028 (USD MILLION) 234
10.3.5 ITALY 234
10.3.5.1 Established telehealth and telespecialty practices and increased geriatric population to drive market 234
TABLE 216 ITALY: TELEHEALTH & TELEMEDICINE MARKET, BY COMPONENT, 2021–2028 (USD MILLION) 235
TABLE 217 ITALY: TELEHEALTH & TELEMEDICINE MARKET FOR SOFTWARE & SERVICES, BY TYPE, 2021–2028 (USD MILLION) 235
TABLE 218 ITALY: TELEHEALTH & TELEMEDICINE MARKET FOR SOFTWARE & SERVICES, BY REVENUE MODEL, 2021–2028 (USD MILLION) 236
TABLE 219 ITALY: TELEHEALTH & TELEMEDICINE MARKET FOR HARDWARE, BY TYPE, 2021–2028 (USD MILLION) 236
TABLE 220 ITALY: MEDICAL PERIPHERAL DEVICES MARKET, BY TYPE, 2021–2028 (USD MILLION) 236
TABLE 221 ITALY: TELEHEALTH & TELEMEDICINE MARKET, BY MODE OF DELIVERY, 2021–2028 (USD MILLION) 237
TABLE 222 ITALY: TELEHEALTH & TELEMEDICINE MARKET, BY APPLICATION, 2021–2028 (USD MILLION) 237
TABLE 223 ITALY: TELEHEALTH & TELEMEDICINE MARKET, BY END USER, 2021–2028 (USD MILLION) 238
TABLE 224 ITALY: TELEHEALTH & TELEMEDICINE MARKET FOR PROVIDERS, BY TYPE 2021–2028 (USD MILLION) 238
TABLE 225 ITALY: TELEHEALTH & TELEMEDICINE MARKET FOR PAYERS, BY TYPE 2021–2028 (USD MILLION) 238
10.3.6 SPAIN 239
10.3.6.1 Rising incidence of chronic diseases and well-organized healthcare system to drive market 239
TABLE 226 SPAIN: TELEHEALTH & TELEMEDICINE MARKET, BY COMPONENT, 2021–2028 (USD MILLION) 239
TABLE 227 SPAIN: TELEHEALTH & TELEMEDICINE MARKET FOR SOFTWARE & SERVICES, BY TYPE, 2021–2028 (USD MILLION) 240
TABLE 228 SPAIN: TELEHEALTH & TELEMEDICINE MARKET FOR SOFTWARE & SERVICES, BY REVENUE MODEL, 2021–2028 (USD MILLION) 240
TABLE 229 SPAIN: TELEHEALTH & TELEMEDICINE MARKET FOR HARDWARE, BY TYPE, 2021–2028 (USD MILLION) 240
TABLE 230 SPAIN: MEDICAL PERIPHERAL DEVICES MARKET, BY TYPE, 2021–2028 (USD MILLION) 241
TABLE 231 SPAIN: TELEHEALTH & TELEMEDICINE MARKET, BY MODE OF DELIVERY, 2021–2028 (USD MILLION) 241
TABLE 232 SPAIN: TELEHEALTH & TELEMEDICINE MARKET, BY APPLICATION, 2021–2028 (USD MILLION) 242
TABLE 233 SPAIN: TELEHEALTH & TELEMEDICINE MARKET, BY END USER, 2021–2028 (USD MILLION) 242
TABLE 234 SPAIN: TELEHEALTH & TELEMEDICINE MARKET FOR PROVIDERS, BY TYPE 2021–2028 (USD MILLION) 243
TABLE 235 SPAIN: TELEHEALTH & TELEMEDICINE MARKET FOR PAYERS, BY TYPE 2021–2028 (USD MILLION) 243
10.3.7 REST OF EUROPE 243
TABLE 236 REST OF EUROPE: TELEHEALTH & TELEMEDICINE MARKET, BY COMPONENT, 2021–2028 (USD MILLION) 244
TABLE 237 REST OF EUROPE: TELEHEALTH & TELEMEDICINE MARKET FOR SOFTWARE & SERVICES, BY TYPE, 2021–2028 (USD MILLION) 244
TABLE 238 REST OF EUROPE: TELEHEALTH & TELEMEDICINE MARKET FOR SOFTWARE & SERVICES, BY REVENUE MODEL, 2021–2028 (USD MILLION) 245
TABLE 239 REST OF EUROPE: TELEHEALTH & TELEMEDICINE MARKET FOR HARDWARE, BY TYPE, 2021–2028 (USD MILLION) 245
TABLE 240 REST OF EUROPE: MEDICAL PERIPHERAL DEVICES MARKET, BY TYPE, 2021–2028 (USD MILLION) 246
TABLE 241 REST OF EUROPE: TELEHEALTH & TELEMEDICINE MARKET, BY MODE OF DELIVERY, 2021–2028 (USD MILLION) 246
TABLE 242 REST OF EUROPE: TELEHEALTH & TELEMEDICINE MARKET, BY APPLICATION, 2021–2028 (USD MILLION) 247
TABLE 243 REST OF EUROPE: TELEHEALTH & TELEMEDICINE MARKET, BY END USER, 2021–2028 (USD MILLION) 247
TABLE 244 REST OF EUROPE: TELEHEALTH & TELEMEDICINE MARKET FOR PROVIDERS, BY TYPE 2021–2028 (USD MILLION) 248
TABLE 245 REST OF EUROPE: TELEHEALTH & TELEMEDICINE MARKET FOR PAYERS, BY TYPE 2021–2028 (USD MILLION) 248
10.4 ASIA PACIFIC 248
FIGURE 36 ASIA PACIFIC: TELEHEALTH & TELEMEDICINE MARKET SNAPSHOT 250
TABLE 246 ASIA PACIFIC: TELEHEALTH & TELEMEDICINE MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 251
TABLE 247 ASIA PACIFIC: TELEHEALTH & TELEMEDICINE MARKET, BY COMPONENT, 2021–2028 (USD MILLION) 251
TABLE 248 ASIA PACIFIC: TELEHEALTH & TELEMEDICINE MARKET FOR SOFTWARE & SERVICES, BY TYPE, 2021–2028 (USD MILLION) 252
TABLE 249 ASIA PACIFIC: TELEHEALTH & TELEMEDICINE MARKET FOR SOFTWARE & SERVICES, BY REVENUE MODEL, 2021–2028 (USD MILLION) 252
TABLE 250 ASIA PACIFIC: TELEHEALTH & TELEMEDICINE MARKET FOR HARDWARE, BY TYPE, 2021–2028 (USD MILLION) 252
TABLE 251 ASIA PACIFIC: MEDICAL PERIPHERAL DEVICES MARKET, BY TYPE, 2021–2028 (USD MILLION) 253
TABLE 252 ASIA PACIFIC: TELEHEALTH & TELEMEDICINE MARKET, BY MODE OF DELIVERY, 2021–2028 (USD MILLION) 253
TABLE 253 ASIA PACIFIC: TELEHEALTH & TELEMEDICINE MARKET, BY APPLICATION, 2021–2028 (USD MILLION) 254
TABLE 254 ASIA PACIFIC: TELEHEALTH & TELEMEDICINE MARKET, BY END USER, 2021–2028 (USD MILLION) 254
TABLE 255 ASIA PACIFIC: TELEHEALTH & TELEMEDICINE MARKET FOR PROVIDERS, BY TYPE 2021–2028 (USD MILLION) 255
TABLE 256 ASIA PACIFIC: TELEHEALTH & TELEMEDICINE MARKET FOR PAYERS, BY TYPE 2021–2028 (USD MILLION) 255
10.4.1 ASIA PACIFIC: RECESSION IMPACT 255
10.4.2 CHINA 256
10.4.2.1 Opportunities for advanced internet-based telehealth platforms to drive market 256
TABLE 257 CHINA: TELEHEALTH & TELEMEDICINE MARKET, BY COMPONENT, 2021–2028 (USD MILLION) 256
TABLE 258 CHINA: TELEHEALTH & TELEMEDICINE MARKET FOR SOFTWARE & SERVICES, BY TYPE, 2021–2028 (USD MILLION) 257
TABLE 259 CHINA: TELEHEALTH & TELEMEDICINE MARKET FOR SOFTWARE & SERVICES, BY REVENUE MODEL, 2021–2028 (USD MILLION) 257
TABLE 260 CHINA: TELEHEALTH & TELEMEDICINE MARKET FOR HARDWARE, BY TYPE, 2021–2028 (USD MILLION) 257
TABLE 261 CHINA: MEDICAL PERIPHERAL DEVICES MARKET, BY TYPE, 2021–2028 (USD MILLION) 258
TABLE 262 CHINA: TELEHEALTH & TELEMEDICINE MARKET, BY MODE OF DELIVERY, 2021–2028 (USD MILLION) 258
TABLE 263 CHINA: TELEHEALTH & TELEMEDICINE MARKET, BY APPLICATION, 2021–2028 (USD MILLION) 259
TABLE 264 CHINA: TELEHEALTH & TELEMEDICINE MARKET, BY END USER, 2021–2028 (USD MILLION) 259
TABLE 265 CHINA: TELEHEALTH & TELEMEDICINE MARKET FOR PROVIDERS, BY TYPE 2021–2028 (USD MILLION) 260
TABLE 266 CHINA: TELEHEALTH & TELEMEDICINE MARKET FOR PAYERS, BY TYPE 2021–2028 (USD MILLION) 260
10.4.3 JAPAN 260
10.4.3.1 Rise in geriatric population and well-established health insurance system to drive market 260
TABLE 267 JAPAN: TELEHEALTH & TELEMEDICINE MARKET, BY COMPONENT, 2021–2028 (USD MILLION) 261
TABLE 268 JAPAN: TELEHEALTH & TELEMEDICINE MARKET FOR SOFTWARE & SERVICES, BY TYPE, 2021–2028 (USD MILLION) 262
TABLE 269 JAPAN: TELEHEALTH & TELEMEDICINE MARKET FOR SOFTWARE & SERVICES, BY REVENUE MODEL, 2021–2028 (USD MILLION) 262
TABLE 270 JAPAN: TELEHEALTH & TELEMEDICINE MARKET FOR HARDWARE, BY TYPE, 2021–2028 (USD MILLION) 262
TABLE 271 JAPAN: MEDICAL PERIPHERAL DEVICES MARKET, BY TYPE, 2021–2028 (USD MILLION) 263
TABLE 272 JAPAN: TELEHEALTH & TELEMEDICINE MARKET, BY MODE OF DELIVERY, 2021–2028 (USD MILLION) 263
TABLE 273 JAPAN: TELEHEALTH & TELEMEDICINE MARKET, BY APPLICATION, 2021–2028 (USD MILLION) 264
TABLE 274 JAPAN: TELEHEALTH & TELEMEDICINE MARKET, BY END USER, 2021–2028 (USD MILLION) 264
TABLE 275 JAPAN: TELEHEALTH & TELEMEDICINE MARKET FOR PROVIDERS, BY TYPE 2021–2028 (USD MILLION) 265
TABLE 276 JAPAN: TELEHEALTH & TELEMEDICINE MARKET FOR PAYERS, BY TYPE 2021–2028 (USD MILLION) 265
10.4.4 INDIA 265
10.4.4.1 Favorable government policies and high density of rural population to drive market 265
TABLE 277 INDIA: TELEHEALTH & TELEMEDICINE MARKET, BY COMPONENT, 2021–2028 (USD MILLION) 267
TABLE 278 INDIA: TELEHEALTH & TELEMEDICINE MARKET FOR SOFTWARE & SERVICES, BY TYPE, 2021–2028 (USD MILLION) 267
TABLE 279 INDIA: TELEHEALTH & TELEMEDICINE MARKET FOR SOFTWARE & SERVICES, BY REVENUE MODEL, 2021–2028 (USD MILLION) 267
TABLE 280 INDIA: TELEHEALTH & TELEMEDICINE MARKET FOR HARDWARE, BY TYPE, 2021–2028 (USD MILLION) 268
TABLE 281 INDIA: MEDICAL PERIPHERAL DEVICES MARKET, BY TYPE, 2021–2028 (USD MILLION) 268
TABLE 282 INDIA: TELEHEALTH & TELEMEDICINE MARKET, BY MODE OF DELIVERY, 2021–2028 (USD MILLION) 268
TABLE 283 INDIA: TELEHEALTH & TELEMEDICINE MARKET, BY APPLICATION, 2021–2028 (USD MILLION) 269
TABLE 284 INDIA: TELEHEALTH & TELEMEDICINE MARKET, BY END USER, 2021–2028 (USD MILLION) 269
TABLE 285 INDIA: TELEHEALTH & TELEMEDICINE MARKET FOR PROVIDERS, BY TYPE 2021–2028 (USD MILLION) 270
TABLE 286 INDIA: TELEHEALTH & TELEMEDICINE MARKET FOR PAYERS, BY TYPE 2021–2028 (USD MILLION) 270
10.4.5 AUSTRALIA 270
10.4.5.1 Favorable government initiatives and healthcare policies to drive market 270
TABLE 287 AUSTRALIA: TELEHEALTH & TELEMEDICINE MARKET, BY COMPONENT, 2021–2028 (USD MILLION) 271
TABLE 288 AUSTRALIA: TELEHEALTH & TELEMEDICINE MARKET FOR SOFTWARE & SERVICES, BY TYPE, 2021–2028 (USD MILLION) 271
TABLE 289 AUSTRALIA: TELEHEALTH & TELEMEDICINE MARKET FOR SOFTWARE & SERVICES, BY REVENUE MODEL, 2021–2028 (USD MILLION) 272
TABLE 290 AUSTRALIA: TELEHEALTH & TELEMEDICINE MARKET FOR HARDWARE, BY TYPE, 2021–2028 (USD MILLION) 272
TABLE 291 AUSTRALIA: MEDICAL PERIPHERAL DEVICES MARKET, BY TYPE, 2021–2028 (USD MILLION) 272
TABLE 292 AUSTRALIA: TELEHEALTH & TELEMEDICINE MARKET, BY MODE OF DELIVERY, 2021–2028 (USD MILLION) 273
TABLE 293 AUSTRALIA: TELEHEALTH & TELEMEDICINE MARKET, BY APPLICATION, 2021–2028 (USD MILLION) 273
TABLE 294 AUSTRALIA: TELEHEALTH & TELEMEDICINE MARKET, BY END USER, 2021–2028 (USD MILLION) 274
TABLE 295 AUSTRALIA: TELEHEALTH & TELEMEDICINE MARKET FOR PROVIDERS, BY TYPE 2021–2028 (USD MILLION) 274
TABLE 296 AUSTRALIA: TELEHEALTH & TELEMEDICINE MARKET FOR PAYERS, BY TYPE 2021–2028 (USD MILLION) 274
10.4.6 REST OF ASIA PACIFIC 275
TABLE 297 REST OF ASIA PACIFIC: TELEHEALTH & TELEMEDICINE MARKET, BY COMPONENT, 2021–2028 (USD MILLION) 275
TABLE 298 REST OF ASIA PACIFIC: TELEHEALTH & TELEMEDICINE MARKET FOR SOFTWARE & SERVICES, BY TYPE, 2021–2028 (USD MILLION) 276
TABLE 299 REST OF ASIA PACIFIC: TELEHEALTH & TELEMEDICINE MARKET FOR SOFTWARE & SERVICES, BY REVENUE MODEL, 2021–2028 (USD MILLION) 276
TABLE 300 REST OF ASIA PACIFIC: TELEHEALTH & TELEMEDICINE MARKET FOR HARDWARE, BY TYPE, 2021–2028 (USD MILLION) 276
TABLE 301 REST OF ASIA PACIFIC: MEDICAL PERIPHERAL DEVICES MARKET, BY TYPE, 2021–2028 (USD MILLION) 277
TABLE 302 REST OF ASIA PACIFIC: TELEHEALTH & TELEMEDICINE MARKET, BY MODE OF DELIVERY, 2021–2028 (USD MILLION) 277
TABLE 303 REST OF ASIA PACIFIC: TELEHEALTH & TELEMEDICINE MARKET, BY APPLICATION, 2021–2028 (USD MILLION) 278
TABLE 304 REST OF ASIA PACIFIC: TELEHEALTH & TELEMEDICINE MARKET, BY END USER, 2021–2028 (USD MILLION) 278
TABLE 305 REST OF ASIA PACIFIC: TELEHEALTH & TELEMEDICINE MARKET FOR PROVIDERS, BY TYPE 2021–2028 (USD MILLION) 279
TABLE 306 REST OF ASIA PACIFIC: TELEHEALTH & TELEMEDICINE MARKET FOR PAYERS, BY TYPE 2021–2028 (USD MILLION) 279
10.5 LATIN AMERICA 279
TABLE 307 LATIN AMERICA: TELEHEALTH & TELEMEDICINE MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 280
TABLE 308 LATIN AMERICA: TELEHEALTH & TELEMEDICINE MARKET, BY COMPONENT, 2021–2028 (USD MILLION) 280
TABLE 309 LATIN AMERICA: TELEHEALTH & TELEMEDICINE MARKET FOR SOFTWARE & SERVICES, BY TYPE, 2021–2028 (USD MILLION) 281
TABLE 310 LATIN AMERICA: TELEHEALTH & TELEMEDICINE MARKET FOR SOFTWARE & SERVICES, BY REVENUE MODEL, 2021–2028 (USD MILLION) 281
TABLE 311 LATIN AMERICA: TELEHEALTH & TELEMEDICINE MARKET FOR HARDWARE, BY TYPE, 2021–2028 (USD MILLION) 281
TABLE 312 LATIN AMERICA: MEDICAL PERIPHERAL DEVICES MARKET, BY TYPE, 2021–2028 (USD MILLION) 282
TABLE 313 LATIN AMERICA: TELEHEALTH & TELEMEDICINE MARKET, BY MODE OF DELIVERY, 2021–2028 (USD MILLION) 282
TABLE 314 LATIN AMERICA: TELEHEALTH & TELEMEDICINE MARKET, BY APPLICATION, 2021–2028 (USD MILLION) 283
TABLE 315 LATIN AMERICA: TELEHEALTH & TELEMEDICINE MARKET, BY END USER, 2021–2028 (USD MILLION) 283
TABLE 316 LATIN AMERICA: TELEHEALTH & TELEMEDICINE MARKET FOR PROVIDERS, BY TYPE 2021–2028 (USD MILLION) 284
TABLE 317 LATIN AMERICA: TELEHEALTH & TELEMEDICINE MARKET FOR PAYERS, BY TYPE 2021–2028 (USD MILLION) 284
10.5.1 LATIN AMERICA: RECESSION IMPACT 284
10.5.2 BRAZIL 285
10.5.2.1 Growing focus on reducing government healthcare expenditure to drive market 285
TABLE 318 BRAZIL: TELEHEALTH & TELEMEDICINE MARKET, BY COMPONENT, 2021–2028 (USD MILLION) 285
TABLE 319 BRAZIL: TELEHEALTH & TELEMEDICINE MARKET FOR SOFTWARE & SERVICES, BY TYPE, 2021–2028 (USD MILLION) 286
TABLE 320 BRAZIL: TELEHEALTH & TELEMEDICINE MARKET FOR SOFTWARE & SERVICES, BY REVENUE MODEL, 2021–2028 (USD MILLION) 286
TABLE 321 BRAZIL: TELEHEALTH & TELEMEDICINE MARKET FOR HARDWARE, BY TYPE, 2021–2028 (USD MILLION) 286
TABLE 322 BRAZIL: MEDICAL PERIPHERAL DEVICES MARKET, BY TYPE, 2021–2028 (USD MILLION) 287
TABLE 323 BRAZIL: TELEHEALTH & TELEMEDICINE MARKET, BY MODE OF DELIVERY, 2021–2028 (USD MILLION) 287
TABLE 324 BRAZIL: TELEHEALTH & TELEMEDICINE MARKET, BY APPLICATION, 2021–2028 (USD MILLION) 288
TABLE 325 BRAZIL: TELEHEALTH & TELEMEDICINE MARKET, BY END USER, 2021–2028 (USD MILLION) 288
TABLE 326 BRAZIL: TELEHEALTH & TELEMEDICINE MARKET FOR PROVIDERS, BY TYPE 2021–2028 (USD MILLION) 289
TABLE 327 BRAZIL: TELEHEALTH & TELEMEDICINE MARKET FOR PAYERS, BY TYPE 2021–2028 (USD MILLION) 289
10.5.3 MEXICO 289
10.5.3.1 Increasing demand and adoption of healthcare IT solutions to drive market 289
TABLE 328 MEXICO: TELEHEALTH & TELEMEDICINE MARKET, BY COMPONENT, 2021–2028 (USD MILLION) 290
TABLE 329 MEXICO: TELEHEALTH & TELEMEDICINE MARKET FOR SOFTWARE & SERVICES, BY TYPE, 2021–2028 (USD MILLION) 290
TABLE 330 MEXICO: TELEHEALTH & TELEMEDICINE MARKET FOR SOFTWARE & SERVICES, BY REVENUE MODEL, 2021–2028 (USD MILLION) 290
TABLE 331 MEXICO: TELEHEALTH & TELEMEDICINE MARKET FOR HARDWARE, BY TYPE, 2021–2028 (USD MILLION) 291
TABLE 332 MEXICO: MEDICAL PERIPHERAL DEVICES MARKET, BY TYPE, 2021–2028 (USD MILLION) 291
TABLE 333 MEXICO: TELEHEALTH & TELEMEDICINE MARKET, BY MODE OF DELIVERY, 2021–2028 (USD MILLION) 291
TABLE 334 MEXICO: TELEHEALTH & TELEMEDICINE MARKET, BY APPLICATION, 2021–2028 (USD MILLION) 292
TABLE 335 MEXICO: TELEHEALTH & TELEMEDICINE MARKET, BY END USER, 2021–2028 (USD MILLION) 292
TABLE 336 MEXICO: TELEHEALTH & TELEMEDICINE MARKET FOR PROVIDERS, BY TYPE 2021–2028 (USD MILLION) 293
TABLE 337 MEXICO: TELEHEALTH & TELEMEDICINE MARKET FOR PAYERS, BY TYPE 2021–2028 (USD MILLION) 293
10.5.4 REST OF LATIN AMERICA 293
TABLE 338 REST OF LATIN AMERICA: TELEHEALTH & TELEMEDICINE MARKET, BY COMPONENT, 2021–2028 (USD MILLION) 294
TABLE 339 REST OF LATIN AMERICA: TELEHEALTH & TELEMEDICINE MARKET FOR SOFTWARE & SERVICES, BY TYPE, 2021–2028 (USD MILLION) 294
TABLE 340 REST OF LATIN AMERICA: TELEHEALTH & TELEMEDICINE MARKET FOR SOFTWARE & SERVICES, BY REVENUE MODEL, 2021–2028 (USD MILLION) 295
TABLE 341 REST OF LATIN AMERICA: TELEHEALTH & TELEMEDICINE MARKET FOR HARDWARE, BY TYPE, 2021–2028 (USD MILLION) 295
TABLE 342 REST OF LATIN AMERICA: MEDICAL PERIPHERAL DEVICES MARKET, BY TYPE, 2021–2028 (USD MILLION) 296
TABLE 343 REST OF LATIN AMERICA: TELEHEALTH & TELEMEDICINE MARKET, BY MODE OF DELIVERY, 2021–2028 (USD MILLION) 296
TABLE 344 REST OF LATIN AMERICA: TELEHEALTH & TELEMEDICINE MARKET, BY APPLICATION, 2021–2028 (USD MILLION) 297
TABLE 345 REST OF LATIN AMERICA: TELEHEALTH & TELEMEDICINE MARKET, BY END USER, 2021–2028 (USD MILLION) 297
TABLE 346 REST OF LATIN AMERICA: TELEHEALTH & TELEMEDICINE MARKET FOR PROVIDERS, BY TYPE 2021–2028 (USD MILLION) 298
TABLE 347 REST OF LATIN AMERICA: TELEHEALTH & TELEMEDICINE MARKET FOR PAYERS, BY TYPE 2021–2028 (USD MILLION) 298
10.6 MIDDLE EAST & AFRICA 298
TABLE 348 MIDDLE EAST & AFRICA: TELEHEALTH & TELEMEDICINE MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 299
TABLE 349 MIDDLE EAST & AFRICA: TELEHEALTH & TELEMEDICINE MARKET, BY COMPONENT, 2021–2028 (USD MILLION) 299
TABLE 350 MIDDLE EAST & AFRICA: TELEHEALTH & TELEMEDICINE MARKET FOR SOFTWARE & SERVICES, BY TYPE, 2021–2028 (USD MILLION) 300
TABLE 351 MIDDLE EAST & AFRICA: TELEHEALTH & TELEMEDICINE MARKET FOR SOFTWARE & SERVICES, BY REVENUE MODEL, 2021–2028 (USD MILLION) 300
TABLE 352 MIDDLE EAST & AFRICA: TELEHEALTH & TELEMEDICINE MARKET FOR HARDWARE, BY TYPE, 2021–2028 (USD MILLION) 300
TABLE 353 MIDDLE EAST & AFRICA: MEDICAL PERIPHERAL DEVICES MARKET, BY TYPE, 2021–2028 (USD MILLION) 301
TABLE 354 MIDDLE EAST & AFRICA: TELEHEALTH & TELEMEDICINE MARKET, BY MODE OF DELIVERY, 2021–2028 (USD MILLION) 301
TABLE 355 MIDDLE EAST & AFRICA: TELEHEALTH & TELEMEDICINE MARKET, BY APPLICATION, 2021–2028 (USD MILLION) 302
TABLE 356 MIDDLE EAST & AFRICA: TELEHEALTH & TELEMEDICINE MARKET, BY END USER, 2021–2028 (USD MILLION) 302
TABLE 357 MIDDLE EAST & AFRICA: TELEHEALTH & TELEMEDICINE MARKET FOR PROVIDERS, BY TYPE 2021–2028 (USD MILLION) 303
TABLE 358 MIDDLE EAST & AFRICA: TELEHEALTH & TELEMEDICINE MARKET FOR PAYERS, BY TYPE 2021–2028 (USD MILLION) 303
10.6.1 MIDDLE EAST & AFRICA: RECESSION IMPACT 303
10.6.2 GCC COUNTRIES 304
10.6.2.1 Rising focus on expanding and improving present health infrastructure to drive market 304
TABLE 359 GCC COUNTRIES: TELEHEALTH & TELEMEDICINE MARKET, BY COMPONENT, 2021–2028 (USD MILLION) 305
TABLE 360 GCC COUNTRIES: TELEHEALTH & TELEMEDICINE MARKET FOR SOFTWARE & SERVICES, BY TYPE, 2021–2028 (USD MILLION) 305
TABLE 361 GCC COUNTRIES: TELEHEALTH & TELEMEDICINE MARKET FOR SOFTWARE & SERVICES, BY REVENUE MODEL, 2021–2028 (USD MILLION) 305
TABLE 362 GCC COUNTRIES: TELEHEALTH & TELEMEDICINE MARKET FOR HARDWARE, BY TYPE, 2021–2028 (USD MILLION) 306
TABLE 363 GCC COUNTRIES: MEDICAL PERIPHERAL DEVICES MARKET, BY TYPE, 2021–2028 (USD MILLION) 306
TABLE 364 GCC COUNTRIES: TELEHEALTH & TELEMEDICINE MARKET, BY MODE OF DELIVERY, 2021–2028 (USD MILLION) 306
TABLE 365 GCC COUNTRIES: TELEHEALTH & TELEMEDICINE MARKET, BY APPLICATION, 2021–2028 (USD MILLION) 307
TABLE 366 GCC COUNTRIES: TELEHEALTH & TELEMEDICINE MARKET, BY END USER, 2021–2028 (USD MILLION) 307
TABLE 367 GCC COUNTRIES: TELEHEALTH & TELEMEDICINE MARKET FOR PROVIDERS, BY TYPE 2021–2028 (USD MILLION) 308
TABLE 368 GCC COUNTRIES: TELEHEALTH & TELEMEDICINE MARKET FOR PAYERS, BY TYPE 2021–2028 (USD MILLION) 308
10.6.3 REST OF MIDDLE EAST & AFRICA 308
TABLE 369 REST OF MIDDLE EAST & AFRICA: TELEHEALTH & TELEMEDICINE MARKET, BY COMPONENT, 2021–2028 (USD MILLION) 309
TABLE 370 REST OF MIDDLE EAST & AFRICA: TELEHEALTH & TELEMEDICINE MARKET FOR SOFTWARE & SERVICES, BY TYPE, 2021–2028 (USD MILLION) 309
TABLE 371 REST OF MIDDLE EAST & AFRICA: TELEHEALTH & TELEMEDICINE MARKET FOR SOFTWARE & SERVICES, BY REVENUE MODEL, 2021–2028 (USD MILLION) 310
TABLE 372 REST OF MIDDLE EAST & AFRICA: TELEHEALTH & TELEMEDICINE MARKET FOR HARDWARE, BY TYPE, 2021–2028 (USD MILLION) 310
TABLE 373 REST OF MIDDLE EAST & AFRICA: MEDICAL PERIPHERAL DEVICES MARKET, BY TYPE, 2021–2028 (USD MILLION) 311
TABLE 374 REST OF MIDDLE EAST & AFRICA: TELEHEALTH & TELEMEDICINE MARKET, BY MODE OF DELIVERY, 2021–2028 (USD MILLION) 311
TABLE 375 REST OF MIDDLE EAST & AFRICA: TELEHEALTH & TELEMEDICINE MARKET, BY APPLICATION, 2021–2028 (USD MILLION) 312
TABLE 376 REST OF MIDDLE EAST & AFRICA: TELEHEALTH & TELEMEDICINE MARKET, BY END USER, 2021–2028 (USD MILLION) 312
TABLE 377 REST OF MIDDLE EAST & AFRICA: TELEHEALTH & TELEMEDICINE MARKET FOR PROVIDERS, BY TYPE 2021–2028 (USD MILLION) 313
TABLE 378 REST OF MIDDLE EAST & AFRICA: TELEHEALTH & TELEMEDICINE MARKET FOR PAYERS, BY TYPE 2021–2028 (USD MILLION) 313
11 COMPETITIVE LANDSCAPE 314
11.1 INTRODUCTION 314
11.2 KEY PLAYER STRATEGIES/RIGHT TO WIN 314
FIGURE 37 KEY STRATEGIES ADOPTED BY MAJOR PLAYERS, JANUARY 2020– NOVEMBER 2023 315
11.3 REVENUE SHARE ANALYSIS 316
FIGURE 38 REVENUE SHARE ANALYSIS, 2018–2022 316
11.4 MARKET SHARE ANALYSIS 316
FIGURE 39 MARKET SHARE ANALYSIS, 2022 317
11.5 COMPANY EVALUATION MATRIX 319
11.5.1 STARS 319
11.5.2 EMERGING LEADERS 319
11.5.3 PERVASIVE PLAYERS 319
11.5.4 PARTICIPANTS 319
FIGURE 40 COMPANY EVALUATION MATRIX, 2022 320
11.5.5 COMPANY FOOTPRINT 321
TABLE 379 OVERALL FOOTPRINT 321
TABLE 380 PRODUCT FOOTPRINT 322
TABLE 381 REGIONAL FOOTPRINT 323
11.6 START-UP/SME EVALUATION MATRIX 324
11.6.1 PROGRESSIVE COMPANIES 324
11.6.2 RESPONSIVE COMPANIES 324
11.6.3 DYNAMIC COMPANIES 324
11.6.4 STARTING BLOCKS 324
FIGURE 41 START-UP/SME EVALUATION MATRIX, 2022 325
11.6.5 COMPETITIVE BENCHMARKING 326
TABLE 382 DETAILED LIST OF KEY START-UPS/SMES 326
TABLE 383 COMPETITIVE BENCHMARKING OF START-UPS/SMES 328
11.7 COMPETITIVE SCENARIOS AND TRENDS 329
11.7.1 KEY PRODUCT LAUNCHES 329
TABLE 384 KEY PRODUCT LAUNCHES, JANUARY 2020–SEPTEMBER 2023 329
11.7.2 KEY DEALS 329
TABLE 385 KEY DEALS, JANUARY 2020–SEPTEMBER 2023 330
11.7.3 OTHER KEY DEVELOPMENTS 331
TABLE 386 OTHER KEY DEVELOPMENTS, JANUARY 2020–SEPTEMBER 2023 331
12 COMPANY PROFILES 332
12.1 KEY PLAYERS 332
(Business Overview, Products Offered, Recent Developments, and MnM View (Key strengths/Right to Win, Strategic Choices Made, and Weaknesses and Competitive Threats))*
12.1.1 KONINKLIJKE PHILIPS N.V. 332
TABLE 387 KONINKLIJKE PHILIPS N.V.: COMPANY OVERVIEW 332
FIGURE 42 KONINKLIJKE PHILIPS N.V.: COMPANY SNAPSHOT (2022) 333
12.1.2 MEDTRONIC 337
TABLE 388 MEDTRONIC: COMPANY OVERVIEW 337
FIGURE 43 MEDTRONIC: COMPANY SNAPSHOT (2022) 338
12.1.3 GE HEALTHCARE 342
TABLE 389 GE HEALTHCARE: COMPANY OVERVIEW 342
FIGURE 44 GE HEALTHCARE: COMPANY SNAPSHOT (2022) 343
12.1.4 SIEMENS HEALTHINEERS AG 347
TABLE 390 SIEMENS HEALTHINEERS GMBH: COMPANY OVERVIEW 347
FIGURE 45 SIEMENS HEALTHINEERS: COMPANY SNAPSHOT (2022) 348
12.1.5 CISCO SYSTEMS, INC. 351
TABLE 391 CISCO SYSTEMS, INC.: COMPANY OVERVIEW 351
FIGURE 46 CISCO SYSTEMS, INC.: COMPANY SNAPSHOT (2022) 352
12.1.6 ORACLE 354
TABLE 392 ORACLE: COMPANY OVERVIEW 354
FIGURE 47 ORACLE: COMPANY SNAPSHOT (2022) 355
12.1.7 ASAHI KASEI CORPORATION 358
TABLE 393 ASAHI KASEI CORPORATION: COMPANY OVERVIEW 358
FIGURE 48 ASAHI KASEI CORPORATION: COMPANY SNAPSHOT (2022) 359
12.1.8 IRON BOW TECHNOLOGIES 361
TABLE 394 IRON BOW TECHNOLOGIES: COMPANY OVERVIEW 361
12.1.9 AMERICAN WELL 363
TABLE 395 AMERICAN WELL: COMPANY OVERVIEW 363
12.1.10 TELADOC HEALTH, INC. 366
TABLE 396 TELADOC HEALTH, INC.: COMPANY OVERVIEW 366
FIGURE 49 TELADOC HEALTH, INC.: COMPANY SNAPSHOT (2022) 367
12.1.11 AMC HEALTH 370
TABLE 397 AMC HEALTH: COMPANY OVERVIEW 370
12.1.12 TELESPECIALISTS 372
TABLE 398 TELESPECIALISTS: COMPANY OVERVIEW 372
12.1.13 DOCTOR ON DEMAND, INC. 374
TABLE 399 DOCTOR ON DEMAND, INC.: COMPANY OVERVIEW 374
12.1.14 EVERNORTH HEALTH, INC. 376
TABLE 400 EVERNORTH HEALTH, INC.: COMPANY OVERVIEW 376
FIGURE 50 EVERNORTH HEALTH, INC.: COMPANY SNAPSHOT (2022) 376
12.1.15 GLOBAL MEDIA GROUP LLC 378
TABLE 401 GLOBAL MEDIA GROUP: COMPANY OVERVIEW 378
12.1.16 MEDVIVO GROUP LTD. 380
TABLE 402 MEDVIVO GROUP LTD.: COMPANY OVERVIEW 380
12.2 OTHER PLAYERS 381
12.2.1 MEDWEB 381
12.2.2 VSEE 381
12.2.3 IMEDI PLUS 382
12.2.4 ZIPNOSIS 382
12.2.5 ACL DIGITAL 383
12.2.6 ICLINIQ 384
12.2.7 BOSTON SCIENTIFIC CARDIAC DIAGNOSTICS INC. 384
12.2.8 RESIDEO LIFE CARE SOLUTIONS 385
*Details on Business Overview, Products Offered, Recent Developments, and MnM View (Key strengths/Right to Win, Strategic Choices Made, and Weaknesses and Competitive Threats) might not be captured in case of unlisted companies.
13 APPENDIX 386
13.1 DISCUSSION GUIDE 386
13.2 KNOWLEDGESTORE: MARKETSANDMARKETS’ SUBSCRIPTION PORTAL 391
13.3 CUSTOMIZATION OPTIONS 393
13.4 RELATED REPORTS 393
13.5 AUTHOR DETAILS 394
❖ 免責事項 ❖
http://www.globalresearch.jp/disclaimer



 
			 
					
							
			 
					
							
			 
					
							
			 
					
							
			 
					
							
			 
					
							
			 
					
							
			 
					
							
			